No other significant associations between total/sub-domain scores (parent-proxy/child report) for PeLTQL and liver disease diagnosis, immunosuppression (type/dose), cumulative number of episode of acute or chronic rejection, laboratory biochemistries (AST, ALT, ΥGT, total bilirubin, albumin, PT, INR), PELD/MELD, sex, access to rehabilitation services, and anthropometric variables were found (p > 0.05). The gene discussed is GPT; the disease is liver disorder.